Dear Colleagues,

With the new prequalification of ROTASIIL, manufactured by Serum Institute of India, there are now four globally available rotavirus vaccines. Both ROTAVAC, prequalified in January 2018, and ROTASIIL provide different formulations and presentations from other globally available rotavirus vaccines and should have an impact on costs. All four vaccines prequalified by WHO have shown similar efficacy rates in low-income settings. See below for materials on all prequalified rotavirus vaccine products.

There will be much to discuss at the 2018 meeting of the American Society of Tropical Medicine & Hygiene, where ROTA Council will convene a panel on progress, challenges, and the road ahead with rotavirus disease and vaccines. Read more about this and other updates below. 

Mathu Santosham

Chair, ROTA Council


In this Issue

  • Important Updates
  • Upcoming Events
  • New Research
  • Advocacy Tools
  • Member Publications
  • Recent Media
Read the Full Progress Update